Literature DB >> 26603905

Paraquat induce pulmonary epithelial-mesenchymal transition through transforming growth factor-β1-dependent mechanism.

Linshen Xie1, Dingzi Zhou1, Jingyuan Xiong2, Jia You2, Ye Zeng3, Lijun Peng4.   

Abstract

Pulmonary fibrosis is prevalent in Paraquat (PQ) poisoning. Transforming growth factor β1 (TGF-β1)-induced epithelial-mesenchymal transition (EMT) of Type II alveolar epithelial cells (AT2) contributed to the pulmonary fibrosis in some pulmonary disease. In this study, we investigated whether PQ could induce EMT in AT2 through transforming growth factor β1 (TGF-β1) signal pathway in vitro. Morphological and phenotypic characterizations were evaluated on AT2 cell lines A549 cells in the presence of PQ with or without TGF-β1 inhibitors SB431542 for 5 days. As a result, PQ induced the transition of A549 cells from epithelial morphology to fibroblast-like morphology, associated with the acquisition of migratory properties. Phenotypically, PQ induced-EMT was characterized by loss of epithelial cell markers including E-cadherin and zonula occludens (ZO-1), while up-expressions of mesenchymal cell markers including α-smooth muscle actin (α-SMA) and vimentin, concurrent with increased type I collagen (Col I). SB431542 suppressed PQ-induced EMT via inhibiting expressions of phospho-Smad2 and phospho-Smad3. These findings conclusively demonstrated that the cultured A549 cells underwent EMT in the presence of PQ, and suggested that TGF-β1 played a central role in PQ-induced EMT.
Copyright © 2015. Published by Elsevier GmbH.

Entities:  

Keywords:  Epithelial–mesenchymal transition; Paraquat; Transforming growth factor β1 (TGF-β1)

Mesh:

Substances:

Year:  2015        PMID: 26603905     DOI: 10.1016/j.etp.2015.09.010

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  9 in total

1.  Rapamycin protects against paraquat-induced pulmonary epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.

Authors:  Chanthasone Vongphouttha; Jie Zhu; Shuhao Deng; Wenlin Tai; Wenjuan Wu; Zhenkun Li; Wen Lei; Yin Wang; Zhaoxing Dong; Tao Zhang
Journal:  Exp Ther Med       Date:  2018-01-24       Impact factor: 2.447

Review 2.  Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine.

Authors:  Mi Ho Jeong; Hongwei Han; David Lagares; Hyungsoon Im
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-20

3.  Role of epithelial-to-mesenchymal transition in the pulmonary fibrosis induced by paraquat in rats.

Authors:  Jian-Hua Yi; Zhao-Cai Zhang; Mei-Bian Zhang; Xin He; Hao-Ran Lin; Hai-Wen Huang; Hai-Bin Dai; Yu-Wen Huang
Journal:  World J Emerg Med       Date:  2021

4.  Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells.

Authors:  Xin Wang; Jun-Ling Gao; Man-Man Zhao; Hui-Xing Zhu; Yan-Xia Tian; Ran Li; Xiao-Hua Jiang; Lei Yu; Jing-Rui Tian; Jian-Zhong Cui
Journal:  Int J Mol Med       Date:  2017-11-24       Impact factor: 4.101

5.  Glycine-Conjugated Bile Acids Protect RPE Tight Junctions against Oxidative Stress and Inhibit Choroidal Endothelial Cell Angiogenesis In Vitro.

Authors:  Cassandra Warden; Milam A Brantley
Journal:  Biomolecules       Date:  2021-04-23

Review 6.  The effects of epithelial-mesenchymal transitions in COPD induced by cigarette smoke: an update.

Authors:  Xiaoshan Su; Weijing Wu; Zhixing Zhu; Xiaoping Lin; Yiming Zeng
Journal:  Respir Res       Date:  2022-08-31

7.  Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF-β1/Smad Pathway.

Authors:  Sibin Guan; Weiguo Xu; Fengfeng Han; Wen Gu; Lin Song; Wenjing Ye; Qian Liu; Xuejun Guo
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

8.  A review of current studies on cellular and molecular mechanisms underlying pulmonary fibrosis induced by chemicals.

Authors:  Ha Ryong Kim; Da Young Shin; Kyu Hyuck Chung
Journal:  Environ Health Toxicol       Date:  2018-09-28

9.  Imrecoxib Inhibits Paraquat-Induced Pulmonary Fibrosis through the NF-κB/Snail Signaling Pathway.

Authors:  Haihao Jin
Journal:  Comput Math Methods Med       Date:  2020-10-13       Impact factor: 2.238

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.